All news articles for September 2014

Impax settles lawsuit related to manufacturing issues for $8m

Impax settles lawsuit related to manufacturing issues for $8m

By Zachary Brennan

Hampered by manufacturing issues, Impax Laboratories has decided to settle a lawsuit over allegations related to the issues in order “to eliminate the uncertainty, distraction, burden and expense of further litigation,” the company said in a SEC filing.

FDA says no to anti-addiction rule on Ritalin, painkillers

FDA says no to anti-addiction rule on Ritalin, painkillers

By Fiona Barry

The US Food and Drug Administration has rejected a petition to force drugmakers to reformulate CNS-acting drugs like Adderall, Ritalin, and painkillers to prevent illegal use, but experts say the rule is only a matter of time.

Partnership looks to expand UK drug manufacturing

Partnership looks to expand UK drug manufacturing

By Zachary Brennan

The Medicines Manufacturing Industry Partnership (MMIP) between the ABPI (Association of the British Pharmaceutical Industry), BIA (BioIndustry Association) and a number of companies aims to make the UK a more attractive destination for pharma manufacturing.